[
  {
    "symbol": "TMDX",
    "price": 85.87,
    "beta": 1.44327,
    "volAvg": 631777,
    "mktCap": 2795377632,
    "lastDiv": 0,
    "range": "30.0-90.15",
    "changes": 4.27,
    "companyName": "TransMedics Group, Inc.",
    "currency": "USD",
    "cik": "0001756262",
    "isin": "US89377M1099",
    "cusip": "89377M109",
    "exchange": "NASDAQ Global Market",
    "exchangeShortName": "NASDAQ",
    "industry": "Medical Devices",
    "website": "https://www.transmedics.com",
    "description": "TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.",
    "ceo": "Dr. Waleed H. Hassanein M.D.",
    "sector": "Healthcare",
    "country": "US",
    "fullTimeEmployees": "212",
    "phone": "978 552 0900",
    "address": "200 Minuteman Road",
    "city": "Andover",
    "state": "MA",
    "zip": "01810",
    "dcfDiff": 10.3145,
    "dcf": 58.7555,
    "image": "https://financialmodelingprep.com/image-stock/TMDX.png",
    "ipoDate": "2019-05-02",
    "defaultImage": false,
    "isEtf": false,
    "isActivelyTrading": true,
    "isAdr": false,
    "isFund": false
  }
]